The ROE as of June 2026 (TTM) for Genmab A/S (GMAB) is 14.53%

According to Genmab A/S’s latest financial reports and current stock price. The company's current ROE is 14.53%. This represents a change of 294.24% compared to the average of 3.69% of the last 4 quarters.

Genmab A/S (GMAB) Historical ROE (quarterly & annually)

How has GMAB ROE performed in the past?

The mean historical ROE of Genmab A/S over the last ten years is 18.64%. The current 14.53% ROE has changed -22.05% with respect to the historical average. Over the past ten years (40 quarters), GMAB's ROE was at its highest in in the June 2020 quarter at 18.90%. The ROE was at its lowest in in the September 2017 quarter at -0.10%.

Genmab A/S (GMAB) ROE by Quarter and Year

Discovering the peaks and valleys of Genmab A/S ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genmab A/S (GMAB) Average ROE

How has GMAB ROE performed in the past?

The current ROE of Genmab A/S (GMAB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genmab A/S (GMAB) ROE vs. Peers

How is GMAB’s ROE compared to its peers?

Genmab A/S’s ROE is less than Incyte Corporation (29.31%), less than United Therapeutics Corporation (19.24%), less than Royalty Pharma plc (12.67%), less than Tenet Healthcare Corporation (40.55%), less than Illumina, Inc. (33.99%), less than Quest Diagnostics Incorporated (14.11%), greater than Roivant Sciences Ltd. (-6.85%), greater than Summit Therapeutics Inc. (-340.55%), less than Zimmer Biomet Holdings, Inc. (5.78%), less than Exelixis, Inc. (40.21%),

Build a custom stock screener for Genmab A/S (GMAB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genmab A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genmab A/S (GMAB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genmab A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.